glp-1 market size 2025 Analogues Size, Share & Growth Forecast to 2035 GLP-1 Analogues Market Size to

A randomized, controlled, comparative, proof-of-concept study to evaluate the efficacy and safety of Nisha-Amalaki capsules in prediabetic patients for preventing progression to diabetes

In terms of actual lung disease, a possible scenario may be that symptoms, including excessive inflammation and oxidative stress, may be tied to these adaptive responses and may only begin to arise when these adaptive responses fail

The autoimmune process itself creates inflammation and can cause symptoms independent of thyroid hormone levels

26, which is below the American Diabetes Association's target of less than 7% for most adults

Commitment: Most patients in 2026 understand that weight regain is common if the medication is stopped without a strict maintenance plan